Having trouble viewing this email? Click Here

Breaking News
   
Hot Issues Tracking—Present and Future of Oncolytic Virus
May 31, 2018
   
CAR-NK: Safer, Cheaper and Better Anti-cancer Drug
July 24, 2018
   
FDA Approved CAR-macrophage Therapy of Ovarian Cancer into Clinical Trials
August 20, 2018
   
Recommended Services/Products
Oncolytic Virus Therapy Development Services
Construction, Engineering, Validation, and Disease-specific oncolytic virotherapy development by our OncoVirapy™ platform.
 
Dendritic Cell Vaccine Development Services
Enhanced DC-based immunotherapy. Engineered DCs. Innovated vaccine technology. Timely troubleshooting.
Technical Topic - Video
  Oncolytic Virotherapy Basic Knowledge Review Creative Biolabs will share some basic knowledge about Chimeric Antigen Receptor or CAR technology and its application on tumor therapy. Watch
     
New Technical Document
  Oncolytic Virus Basis Creative Biolabs creates a comprehensive overview on the basic biology that supports OVs as cancer therapeutic agents, including properties of inherent and engineered oncolytic viruses, mechanisms of viral targeting cancer cells, and mechanisms of action of viruses killing cancer cells. Continue to read
     
Upcoming Meetings & Events in October, 2018
World Immunotherapy Congress
October 29 - 31, 2018. Basel, Switzerland
  36th World Cancer Conference
October 11 - 13, 2018. Hilton Zurich, Switzerland
     
World Biosimilar CongressOctober 29 - 30, 2018. Basel, Switzerland
  10th International Conference on Applied Microbiology and Microbial Biotechnology October 15 - 16, 2018. Ottawa, Canada
 
 
45-1 Ramsey Road, Shirley, NY 11967, USA
©Copyright 2007-2018 Creative-Biolabs
Tel: 1-631-381-2994   Fax: 1-631-207-8356
info@biolabsantibody.com | www.biolabsantibody.com/car-t/

This e-mail has been sent to you by Creative Biolabs. We respect and value your privacy.
If you no longer wish to receive Creative Biolabs's promotional e-mails, click here.